Clinical Trials Logo

Biologics clinical trials

View clinical trials related to Biologics.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04032756 Terminated - Colitis, Ulcerative Clinical Trials

Tofacitinib Registry of Patients With Ulcerative Colitis in Germany

TOFA-UC
Start date: August 1, 2019
Phase:
Study type: Observational [Patient Registry]

This registry on Tofacitinib and biologics (anti-integrin/anti-TNF) in the treatment of ulcerative colitis (UC) patients in Germany will extend the prospective documentation of safety issues and efficacy in induction and maintenance therapy of Tofacitinib (Xeljanz®) in addition to other biologics used in Germany with a particular interest in predictors of long-term responses and favorable disease outcome or to predict severe side effects caused by therapy with Januskinase(JAK)- inhibitors/biologics.